Ticker > Company >

Themis Medicare share price

Themis Medicare Ltd.

NSE: THEMISMED BSE: 530199 SECTOR: Pharmaceuticals & Drugs  48.36 K   68   7

122.12
+20.35 (20.00%)
NSE: Today, 11:54 AM

Price Summary

Today's High

₹ 122.12

Today's Low

₹ 102.9

52 Week High

₹ 317

52 Week Low

₹ 98

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

1123.99 Cr.

Enterprise Value

1194.24 Cr.

No. of Shares

9.2 Cr.

P/E

0

P/B

3.69

Face Value

₹ 1

Div. Yield

0.41 %

Book Value (TTM)

₹  33.13

CASH

12.74 Cr.

DEBT

82.99 Cr.

Promoter Holding

67.15 %

EPS (TTM)

₹  -0.96

Sales Growth

6.22%

ROE

7.7 %

ROCE

10.95%

Profit Growth

-3.34 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year6.22%
3 Year0.91%
5 Year15%

Profit Growth

1 Year-3.34%
3 Year-27.03%
5 Year8.5%

ROE%

1 Year7.7%
3 Year10.89%
5 Year15.37%

ROCE %

1 Year10.95%
3 Year14.02%
5 Year18.06%

Debt/Equity

0.2591

Price to Cash Flow

32.38

Interest Cover Ratio

4.3631

CFO/PAT (5 Yr. Avg.)

0.911486150038886

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 67.15 2.43
Mar 2025 67.15 2.43
Dec 2024 67.15 2.43
Sep 2024 67.15 2.43
Jun 2024 67.15 2.43
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of 63.3079 days.
  • The company has a high promoter holding of 67.15%.

 Limitations

  • The company has shown a poor profit growth of -27.025912241619% for the Past 3 years.
  • The company has shown a poor revenue growth of 0.912164495313261% for the Past 3 years.
  • The company is trading at a high PE of 0.
  • The company is trading at a high EV/EBITDA of 84.4189.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 122.99 99.59 93.81 71.7 97.58
Total Expenditure 93.81 82.57 85.28 77.48 107.66
Operating Profit 29.18 17.02 8.53 -5.78 -10.08
Other Income 0.96 0.77 1.02 1.55 1.18
Interest 2.36 1.6 2.79 2.45 2.47
Depreciation 2.41 1.06 2.54 2.53 2.55
Exceptional Items 0 0 0 0 -1.29
Profit Before Tax 25.38 15.13 4.22 -9.21 -15.22
Tax 6.66 3.95 1.14 -1.46 0.16
Profit After Tax 18.71 11.19 3.08 -7.74 -15.37
Adjusted EPS (Rs) 2.03 1.22 0.33 -0.84 -1.67

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 230.67 394.61 354.32 381.76 405.51
Total Expenditure 180.79 298.96 286.86 330.23 356.45
Operating Profit 49.88 95.65 67.46 51.53 49.06
Other Income 3.62 6.54 11.5 4.76 4.67
Interest 12.71 8.77 9.56 9.38 10.04
Depreciation 8.55 9.48 10.49 12.25 9.93
Exceptional Items 0 0 0 0 0
Profit Before Tax 32.25 83.94 58.91 34.67 33.76
Tax 5.63 22.38 15.61 9.92 9.84
Net Profit 26.62 61.56 43.29 24.75 23.92
Adjusted EPS (Rs.) 2.9 6.69 4.7 2.69 2.6

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 9.19 9.2 9.2 9.2 9.2
Total Reserves 176.61 234.28 272.62 292.07 311.08
Borrowings 22.2 23.88 28.45 26.77 18.61
Other N/C liabilities 2.13 6.89 6.94 9 10.7
Current liabilities 128.27 123.48 149.32 162.22 165.93
Total Liabilities 338.4 397.74 466.54 499.27 515.52
Assets
Net Block 133.1 144 162.2 168.36 172.36
Capital WIP 2.47 2.56 2.6 2.6 2.51
Intangible WIP 0 0 0 0 0
Investments 10.98 11.01 11.07 11.17 11.11
Loans & Advances 2.83 6.9 12.81 12.46 13.34
Other N/C Assets 2.31 3.84 1.82 0.93 1.18
Current Assets 186.72 229.42 276.05 303.74 315.02
Total Assets 338.4 397.74 466.54 499.27 515.52
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 32.25 83.94 58.91 34.67 33.76
Adjustment 17.13 11.1 13.66 17.32 16.82
Changes in Assets & Liabilities 7.52 -42.57 -40.34 -20.99 -5.12
Tax Paid 0.08 -18.07 -16.15 -8.96 -10.75
Operating Cash Flow 56.98 34.39 16.07 22.04 34.71
Investing Cash Flow -15.65 -15.58 -23.96 -15.96 -12.17
Financing Cash Flow -25.65 -17.55 0.14 -8.77 -25.9
Net Cash Flow 15.68 1.26 -7.75 -2.68 -3.36

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 67.15 67.15 67.15 67.15 67.15
anay rupen choksi 1.28 1.28 1.28 1.28 1.28
dinesh s patel huf - 1.07 1.07 1.07 1.07
dinesh shantilal patel 9.47 9.47 9.47 9.47 9.47
gedeon richter investment... 9.61 9.61 9.61 9.61 9.61
jayshree d patel 7.25 7.25 7.25 7.25 7.25
nysha rupen choksi 1.28 1.28 1.28 1.28 1.28
reena s patel 4.04 4.04 4.04 4.04 4.04
sachin dinesh patel 5.99 5.99 5.99 5.99 5.99
shantilal dahyabhai patel... 0.61 0.61 0.61 0.61 0.61
themis distributors priva... - 2.98 2.98 2.98 2.98
vividh distributors pvt l... - 7.78 7.78 7.78 7.78
vividhmargi investments p... - - - - 15.78
vividhmargi investments p... - 15.78 15.78 15.78 -
dinesh s patel (huf) 1.07 - - - -
themis distributors priva... 2.98 - - - -
vividh distributors priva... 7.78 - - - -
vividhmargi investments p... 15.78 - - - -
gedeon richter investment... 9.61 9.61 9.61 9.61 9.61
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 32.85 32.85 32.85 32.85 32.85
anuj anantrai sheth 4.89 4.85 4.67 4.67 4.58
investor education and pr... - - 0.34 0.34 0.34
llp 0.34 0.25 - 0.18 0.17
za capital services india... 1.58 1.53 1.53 1.53 1.53
zafar ahmadullah 2.34 2.34 2.11 2.11 2.11
jagat navratna lodha 1.32 1.32 1.05 - -
investor education and pr... 0.34 0.34 - - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2023
Annual Report 2021
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit ACUITE
Credit CARE
Credit ACUITE
Credit CARE
Credit CARE
Credit SMERA
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q2FY24
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY24
Presentation Q3FY24
Presentation Q2FY24
Presentation Q1FY24

Company News

Themis Medicare Stock Price Analysis and Quick Research Report. Is Themis Medicare an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Themis Medicare. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Themis Medicare has a PE ratio of -127.009880395216 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Themis Medicare has ROA of 4.7146% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Themis Medicare has a Current ratio of 1.8985.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Themis Medicare has a ROE of 7.6972%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Themis Medicare has a Debt to Equity ratio of 0.2591 which means that the company has low proportion of debt in its capital.

  • Sales growth: Themis Medicare has reported revenue growth of 6.2214% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Themis Medicare for the current financial year is 12.0988154222962%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Themis Medicare is Rs 0.5 and the yield is 0.4074%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Themis Medicare is Rs -0.9615. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Themis Medicare in Ticker for free. Also, one can get the intrinsic value of Themis Medicare by using Valuation Calculators, which are available with a Finology ONE subscription. 

Themis Medicare FAQs

Q1. What is Themis Medicare share price today?
Ans: The current share price of Themis Medicare is Rs 122.12.

Q2. What is the market capitalisation of Themis Medicare?
Ans: Themis Medicare has a market capitalisation of Rs 1123.99394544 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Themis Medicare?
Ans: The PE ratio of Themis Medicare is -127.009880395216 and the P/B ratio of Themis Medicare is 3.68628540035378, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Themis Medicare share?
Ans: The 52-week high share price of Themis Medicare is Rs 317, and the 52-week low share price of Themis Medicare is Rs 98.

Q5. Does Themis Medicare pay dividends?
Ans: Currently, Themis Medicare pays dividends. Dividend yield of Themis Medicare is around 0.4074%.

Q6. What are the face value and book value of Themis Medicare shares?
Ans: The face value of Themis Medicare shares is Rs 1, while the book value per share of Themis Medicare is around Rs 33.1282. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Themis Medicare?
Ans: Themis Medicare has a total debt of Rs 82.9885 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Themis Medicare?
Ans: The ROE of Themis Medicare is 7.6972% and ROCE of Themis Medicare is 10.946%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Themis Medicare a good buy for the long term?
Ans: The Themis Medicare long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Themis Medicare undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Themis Medicare appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Themis Medicare’s financials?
Ans: You can review Themis Medicare’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Themis Medicare
X